Mast cells exert pro-inflammatory effects of relevance to the pathophyisology of tendinopathy

Por Behzad, Hayedeh, Sharma, Aishwariya, Mousavizadeh, Rouhollah, Lu, Alex, Scott, Alex
Publicado em 2013

Sodium cromolyn reduces expression of CTGF, ADAMTS1 and TIMP3 and modulates post-injury patellar tendon morphology

Por Sharma, Aishwariya, Abraham, Thomas, Sampaio, Arthur, Cowan, Matthew, Underhill, Michael, Scott, Alex
Publicado em 2010

Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-α in Hormone-Resistant Breast Cancers

Por Singh, Kriti, Munuganti, Ravi S. N., Lallous, Nada, Dalal, Kush, Yoon, Ji Soo, Sharma, Aishwariya, Yamazaki, Takeshi, Cherkasov, Artem, Rennie, Paul S.
Publicado no Int J Mol Sci (2018)

Histone H3 Lysine 36 Methylation Targets the Isw1b Remodeling Complex to Chromatin

Por Maltby, Vicki E., Martin, Benjamin J. E., Schulze, Julia M., Johnson, Ian, Hentrich, Thomas, Sharma, Aishwariya, Kobor, Michael S., Howe, LeAnn
Publicado em 2012

Accumulation of Oxidized LDL in the Tendon Tissues of C57BL/6 or Apolipoprotein E Knock-Out Mice That Consume a High Fat Diet: Potential Impact on Tendon Health

Por Grewal, Navdeep, Thornton, Gail M., Behzad, Hayedeh, Sharma, Aishwariya, Lu, Alex, Zhang, Peng, Reid, W. Darlene, Granville, David J., Scott, Alex
Publicado no PLoS One (2014)

Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer

Por Dalal, Kush, Roshan-Moniri, Mani, Sharma, Aishwariya, Li, Huifang, Ban, Fuqiang, Hessein, Mohamed, Hsing, Michael, Singh, Kriti, LeBlanc, Eric, Dehm, Scott, Tomlinson Guns, Emma S., Cherkasov, Artem, Rennie, Paul S.
Publicado em 2014

Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.

Por Dalal, Kush, Roshan-Moniri, Mani, Sharma, Aishwariya, Li, Huifang, Ban, Fuqiang, Hessein, Mohamed, Hsing, Michael, Singh, Kriti, LeBlanc, Eric, Dehm, Scott, Tomlinson Guns, Emma S., Cherkasov, Artem, Rennie, Paul S.
Publicado no J Biol Chem (2014)

Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.

Por Dalal, Kush, Roshan-Moniri, Mani, Sharma, Aishwariya, Li, Huifang, Ban, Fuqiang, Hassona, Mohamed D., Hsing, Michael, Singh, Kriti, LeBlanc, Eric, Dehm, Scott, Tomlinson Guns, Emma S., Cherkasov, Artem, Rennie, Paul S.
Publicado no J Biol Chem (2015)

Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.

Por Dalal, Kush, Roshan-Moniri, Mani, Sharma, Aishwariya, Li, Huifang, Ban, Fuqiang, Hassona, Mohamed D., Hsing, Michael, Singh, Kriti, LeBlanc, Eric, Dehm, Scott, Tomlinson Guns, Emma S., Cherkasov, Artem, Rennie, Paul S.
Publicado no J Biol Chem (2017)

Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner

Por Tam, Kevin J., Dalal, Kush, Hsing, Michael, Cheng, Chi Wing, Khosravi, Shahram, Yenki, Parvin, Tse, Charan, Peacock, James W., Sharma, Aishwariya, Chiang, Yan Ting, Wang, Yuzhuo, Cherkasov, Artem, Rennie, Paul S., Gleave, Martin E., Ong, Christopher J.
Publicado no Oncotarget (2016)

Bypassing drug-resistance mechanisms of prostate cancer with small-molecules that target androgen receptor chromatin interactions

Por Dalal, Kush, Che, Meixia, Que, Nanette S., Sharma, Aishwariya, Yang, Rendong, Lallous, Nada, Borgmann, Hendrik, Ozistanbullu, Deniz, Tse, Ronnie, Ban, Fuqiang, Li, Huifang, Tam, Kevin J., Roshan-Moniri, Mani, LeBlanc, Eric, Gleave, Martin E., Gewirth, Daniel T., Dehm, Scott M., Cherkasov, Artem, Rennie, Paul S.
Publicado no Mol Cancer Ther (2017)